Brighter and Telia sign agreement for subscription services for the Actiste diabetes solution.

The deal means that Brighter’s connected diabetes management solution for insulin-treated diabetes patients, Actiste®, will be available on the Swedish market through Telia’s digital healthcare solution. The deal with Telia, like the partnership initiated with Ericsson in 2015, is an important milestone towards Brighter’s vision for the future of healthcare, and it allows Brighter to move towards the design of a joint launch plan for Actiste.

 “Of course we are very happy to finally have a first mobile operator agreement in place. It is clear that Telia shares our vision and idea about how the world is changing. Patients with chronic illnesses, such as diabetes, will be able to generate data for both their illness and their treatment, which creates a huge value for the patients themselves as well as for the healthcare industry. But researchers, pharmaceutical companies, and society in general also benefit,” explains Truls Sjöstedt, founder and CEO of Brighter.

Patients use Actiste to measure blood sugar levels and can even inject insulin as needed. All these values are automatically logged and communicated to each patient’s personal cloud account via Actiste’s built-in independent wireless connection, enabling patients to share the information with their doctors and health care providers through Telia’s platform.

“For many years, Telia has been a leader in pushing for digitalization in society. We want to work towards creating a closer and better communication between people and healthcare using technology, leading to better, less expensive care, and increasing life satisfaction for everyone with chronic illnesses. This kind of cooperation is another step in that direction,” says Niklas Sundler, head of Telia’s healthcare initiatives.

Brighter will now continue its negotiations with operators in the rest of the world, primarily in Southeast Asia, where the number of diabetes patients and the need for better diabetes care is growing rapidly.

Last fall Brighter entered into a partnership with Ericsson in the mobile health area in order to simplify connecting its equipment. Through Ericsson Device Connection Platform as a Service it will be possible for mobile operators like Telia to connect their customers with Actiste.

“Brighter’s first agreement with an operator that offers Ericsson’s Device Connection Platform as a Service is great news, and it’s a first step towards building more efficient healthcare structures on a global basis, which can improve quality of life for patients and contribute to savings for the health care industry. This agreement strengthens our strategic work with global OEMs and their solutions for connectivity, and it creates a preference for Device Connection Platform as a Service and thereby a larger market for our operators, says Anders Olin, Vice President, Product Area Network Applications, Business Unit IT and Cloud at Ericsson.

The market for data-driven healthcare is thought by many experts to be the world’s fastest growing. The consulting company McKinsey & Company estimates the value of this market to be between 600 and 800 billion USD (April 2015). Diabetes is one of the most costly diseases, with global costs exceeding 670 billion USD per year. In Sweden there are approximately 450,000 people with diabetes (Swedish Diabetes Association 2016) and over 400 million globally. By 2040, the total number of diabetes patients on global scale is expected to grow by 200 million (IDF 2015).

Questions? Please contact:

Henrik Norström, COO
Phone: 46 733 40 30 45

Truls Sjöstedt, CEO
Phone: 46 709 73 46 00

About Actiste
Brighter’s subscription service solution Actiste simplifies insulin-treated diabetes by gathering all the most important functions in a connected device with which the diabetic can measure blood sugar levels, set dosage and inject insulin, as well as automatically log and share information. Such information can be automatically shared with physicians or caretakers through Telia HomeCare.

About Brighter AB (publ)
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and innovative tools, jDome® and Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 76,


About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB +46 (0)8 – 684 211 00,,


Documents & Links